These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1198427)

  • 1. Proceedings: The antithrombotic effect of acetylsalicylic acid, heparin and phenprocoumon in experimental thrombosis.
    Barth P; Zimmermann R; Zieboll J; Lange D
    Thromb Diath Haemorrh; 1975 Nov; 34(2):554-5. PubMed ID: 1198427
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antithrombotic effect of acetylsalicylic acid, heparin and phenprocoumon on the formation of experimental coagulation thrombi].
    Zimmermann R; Barth P; Masche R
    Verh Dtsch Ges Inn Med; 1974; 80():1446-8. PubMed ID: 4454451
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of some antithrombotic drugs on experimental arterial thrombosis.
    Hladovec J
    Cor Vasa; 1975; 17(1):66-74. PubMed ID: 1149460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Peculiarities in the treatment of dialysis patients using phenprocoumon (Marcumar)].
    Held H; Baetzner P; Liebau G; Bundschu HD; Hayduk K
    Verh Dtsch Ges Inn Med; 1975; 81():1013-5. PubMed ID: 1229387
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative studies on the antithrombotic effect of acetylsalicylic acid and anticoagulants on an experimental model of thrombosis].
    Zimmermann R; Zieboll L; Barth P; Lange D
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1946-7. PubMed ID: 1030144
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental thrombosis and treatment with acetylsalicylic acid in animals].
    Meng K
    Med Welt; 1976 Jul; 27(28):1359-62. PubMed ID: 957961
    [No Abstract]   [Full Text] [Related]  

  • 7. [Inhibition of experimental thrombosis by combined administration of acetylsalicylic acid and cumarins].
    Zimmermann R; Barth P; Lindner R
    Verh Dtsch Ges Inn Med; 1973; 79():1319-22. PubMed ID: 4790170
    [No Abstract]   [Full Text] [Related]  

  • 8. The prevention of thrombosis.
    Bove LG
    J Maine Med Assoc; 1974 Oct; 65(10):233-5. PubMed ID: 4610070
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on the influence of anticoagulants on metastase formation of autochthonic hepatomas in the rat (author's transl)].
    Schmähl D
    Arzneimittelforschung; 1975 Oct; 25(10):1621-3. PubMed ID: 173350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of sequelae after myocardial infarct. Results, methods and problems of a prospective multi-center study of the effect of acetylsalicylic acid, phenprocoumon and placebo].
    Breddin HK; Uberla KK
    Verh Dtsch Ges Inn Med; 1980; 86():1338-48. PubMed ID: 7013326
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of the antithrombotic effects of pentoxifylline, acetylsalicylic acid and low molecular weight heparin in the laser model of thrombosis].
    Krupiński K; Breddin HK; Bielawiec M; Płonowski A
    Kardiol Pol; 1992 Mar; 36(3):142-5. PubMed ID: 1318982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thrombosis prevention with heparin and acetylsalicylic acid in elective hip joint surgery].
    Schöndorf TH
    Med Welt; 1979 Feb; 30(5):170-3. PubMed ID: 759806
    [No Abstract]   [Full Text] [Related]  

  • 13. [Aorto-iliac thrombosis in a gelding: treatment with the anticoagulant Phenprocoumon (Marcoumar)].
    Trachsel D; Cohausz O; Scharf G; Wehrli Eser M
    Schweiz Arch Tierheilkd; 2008 Dec; 150(12):613-8. PubMed ID: 19034846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The German-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. On behalf of the German-Austrian Study Group.
    Breddin K; Loew D; Lechner K; Oberla K; Walter E
    Circulation; 1980 Dec; 62(6 Pt 2):V63-72. PubMed ID: 6777073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Extent and quality of anti-coagulation treatment with coumarin derivatives by the Dutch Thrombosis Services].
    van Geest-Daalderop JH; Sturk A; Levi M; Adriaansen HJ
    Ned Tijdschr Geneeskd; 2004 Apr; 148(15):730-5. PubMed ID: 15119208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of thrombosis in the after-care of coronary dilatation and thrombolysis].
    Weber MA; Lorenz RL; Schramm W; Theisen K
    Z Kardiol; 1986; 75 Suppl 5():107-11. PubMed ID: 2950673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fibrinolytic therapy of deep vein thrombosis of the leg and pelvis with streptokinase and urokinase].
    Hasler K; Neumann H
    Med Welt; 1983 Oct; 34(43):1225-9. PubMed ID: 6645913
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fibrinolytic complexes of low-molecular heparin and acetylsalicylic acid].
    Kudriashov BA; Pastorova VE; Liapina LA; Kondashevskaia MV
    Biull Eksp Biol Med; 1992 Jul; 114(8):141-3. PubMed ID: 1334726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A transient mobile left ventricular thrombosis in dilated cardiomyopathy].
    Nesser HJ; Baumgartner G; Markt B; Davogg S
    Wien Med Wochenschr; 1984 Jun; 134(12):284-6. PubMed ID: 6235676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-generation agents: aspirin, heparin and coumarins.
    Mueller RL
    Best Pract Res Clin Haematol; 2004 Mar; 17(1):23-53. PubMed ID: 15171956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.